Alexander Steinle

Alexander Steinle

Auto-generated profile, based on publicly available information

Alexander Steinle

Institute for Molecular Medicine Goethe‐University Frankfurt am Main Frankfurt am Main Germany

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 1999 in Science
Verified
Journal Article
Closed access
SBStefan Bauer
Stefan Bauer
VGVeronika Groh
Veronika Groh
JWJun Wu
Jun Wu
ASAlexander Steinle
Alexander Steinle
JPJoseph H. Phillips
Joseph H. Phillips
TSThomas Spies
Thomas Spies
Stress-inducible MICA, a distant homolog of major histocompatibility complex (MHC) class I, functions as an antigen for γδ T cells and is frequently expressed in epithelial tumors. A receptor for MICA was detected on most γδ T cells, CD8 + αβ T cells, and natural killer (NK) cells and was identified as NKG2D. Effector cells from all these subsets could be stimulated by ligation of NKG2D. Engagement of NKG2D activated cytolytic responses of γδ T cells and NK cells against transfectants and epithelial tumor cells expressing MICA. These results define an activating immunoreceptor-MHC ligand interaction that may promote antitumor NK and T cell responses.

13 March 1998 in Science
Verified
Journal Article
Closed access
PDF file
VGVeronika Groh
Veronika Groh
ASAlexander Steinle
Alexander Steinle
SBStefan Bauer
Stefan Bauer
TSThomas Spies
Thomas Spies
T cells with variable region V δ 1 γδ T cell receptors (TCRs) are distributed throughout the human intestinal epithelium and may function as sentinels that respond to self antigens. The expression of a major histocompatibility complex (MHC) class I–related molecule, MICA, matches this localization. MICA and the closely related MICB were recognized by intestinal epithelial T cells expressing diverse V δ 1 γδ TCRs. These interactions involved the α1α2 domains of MICA and MICB but were independent of antigen processing. With intestinal epithelial cell lines, the expression and recognition of MICA and MICB could be stress-induced. Thus, these molecules may broadly regulate protective responses by the V δ 1 γδ T cells in the epithelium of the intestinal tract.

6 October 2008 in Oncogene
Verified
Journal Article
Closed access
IWI Waldhauer
I Waldhauer
ASA Steinle
A Steinle

15 October 2002 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
HSHelmut R. Salih
Helmut R. Salih
HRHans-Georg Rammensee
Hans-Georg Rammensee
ASAlexander Steinle
Alexander Steinle
The immunoreceptor NKG2D stimulates tumor immunity through activation of CD8 T cells and NK cells. Its ligand MICA has been shown to be broadly expressed on human tumors of epithelial origin. MICA expression correlates with an enrichment of Vδ1 T cells in tumor tissue. We report that human tumor cells spontaneously release a soluble form of MICA encompassing the three extracellular domains, which is present at high levels in sera of patients with gastrointestinal malignancies, but not in healthy donors. Release of MICA from tumor cells is blocked by inhibition of metalloproteinases, concomitantly causing accumulation of MICA on the cell surface. Shedding of MICA by tumor cells may modulate NKG2D-mediated tumor immune surveillance. In addition, determination of soluble MICA levels may be implemented as an immunological diagnostic marker in patients with epithelial malignancies.

15 August 2003 in Blood
Verified
Journal Article
Closed access
PDF file
HSHelmut Rainer Salih
Helmut Rainer Salih
HAHolger Antropius
Holger Antropius
FGFriederike Gieseke
Friederike Gieseke
SLStefan Zoltan Lutz
Stefan Zoltan Lutz
LKLothar Kanz
Lothar Kanz
ASAlexander Steinle
Alexander Steinle
NKG2D ligands (NKG2DLs) mark malignant cells for recognition by natural killer (NK) cells and cytotoxic T lymphocytes via the activating immunoreceptor NKG2D. This led to the hypothesis that NKG2DLs play a critical role in tumor immune surveillance. The human NKG2DLs MICA and MICB are expressed on tumors of epithelial origin in vivo. For the other recently described set of human NKG2DLs, the UL16-binding proteins (ULBPs), expression in vivo is as yet undefined. In this study we investigated expression and function of NKG2DLs in leukemia using a panel of newly generated NKG2DL-specific monoclonal antibodies. We report that leukemia cells from patients variously express MIC and ULBP molecules on the cell surface with MICA most frequently detected. Patient leukemia cells expressing MICA were lysed by NK cells in an NKG2D-dependent fashion. Sera of patients, but not of healthy donors, contained elevated levels of soluble MICA (sMICA). We also detected increased sMICB levels in patient sera using a newly established MICB-specific enzyme-linked immunosorbent assay. Reduction of leukemia MIC surface expression by shedding may impair NKG2D-mediated immune surveillance of leukemias. In addition, determination of sMICA and sMICB levels may be implemented as a prognostic parameter in patients with hematopoietic malignancies.

1 May 2001 in Immunogenetics
Verified
Journal Article
Closed access
PDF file
ASAlexander Steinle
Alexander Steinle
PLPingwei Li
Pingwei Li
DMDaniel L. Morris
Daniel L. Morris
VGVeronika Groh
Veronika Groh
LLLewis L. Lanier
Lewis L. Lanier
TSThomas Spies
Thomas Spies